14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CNAT
Delisted

Conatus Pharmaceuticals Inc. Stock Price (Quote)

$0.255
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.255 $0.255 Friday, 27th May 2022 CNAT stock ended at $0.255. During the day the stock fluctuated 0% from a day low at $0.255 to a day high of $0.255.
90 days $0.238 $0.275
52 weeks $0.203 $1.23

Historical Conatus Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jun 02, 2021 $1.01 $1.05 $1.01 $1.02 469 734
Jun 01, 2021 $0.99 $1.02 $0.99 $1.01 228 520
May 28, 2021 $1.00 $1.02 $0.99 $0.99 250 463
May 27, 2021 $0.95 $1.01 $0.95 $1.00 395 400
May 26, 2021 $0.99 $1.00 $0.96 $0.96 361 880
May 25, 2021 $0.99 $1.00 $0.95 $0.95 283 234
May 24, 2021 $1.00 $1.04 $0.96 $0.99 579 384
May 21, 2021 $1.01 $1.05 $1.00 $1.03 225 116
May 20, 2021 $1.01 $1.03 $1.00 $1.01 277 745
May 19, 2021 $1.00 $1.01 $0.97 $1.01 187 958
May 18, 2021 $0.99 $1.04 $0.97 $1.00 246 065
May 17, 2021 $0.94 $1.00 $0.92 $0.99 276 133
May 14, 2021 $0.91 $0.95 $0.91 $0.94 186 568
May 13, 2021 $0.96 $0.98 $0.90 $0.90 425 326
May 12, 2021 $0.97 $0.98 $0.94 $0.96 315 008
May 11, 2021 $0.94 $0.97 $0.93 $0.95 404 127
May 10, 2021 $1.01 $1.01 $0.96 $0.96 343 029
May 07, 2021 $1.00 $1.03 $0.98 $0.99 269 809
May 06, 2021 $1.02 $1.03 $0.96 $0.97 570 354
May 05, 2021 $1.06 $1.07 $1.02 $1.03 358 599
May 04, 2021 $1.09 $1.09 $1.00 $1.06 667 303
May 03, 2021 $1.15 $1.16 $1.08 $1.10 499 599
Apr 30, 2021 $1.13 $1.17 $1.10 $1.16 495 648
Apr 29, 2021 $1.15 $1.18 $1.08 $1.13 849 336
Apr 28, 2021 $1.03 $1.18 $1.03 $1.14 3 196 103
Click to get the best stock tips daily for free!

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals. Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... CNAT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT